340B Under Pressure: Why Strong Consulting Matters More Than Ever

This year has been a defining one for hospitals participating in the 340B Drug Pricing Program.

For years, this program has been a lifeline, allowing healthcare organizations to stretch resources and serve vulnerable communities. But in 2025, challenges intensified — making the need for strategic, hands-on support undeniable.

At its heart, 340B is about impact: giving hospitals the ability to provide free or subsidized medications and services for those who need them most. Yet, even small changes in regulations or pricing structures can create ripples across entire organizations. Suddenly, pharmacies, nursing teams, and finance departments are forced to pivot, often in real-time.

This is where RDF Consulting Group has stepped in.

Over our first year in business, we witnessed firsthand how fragile even the most well-intentioned systems can be. The slightest oversight in workflow, documentation, or financial planning can have a profound effect on patient access and organizational sustainability.

Our approach is deeply rooted in practical experience. With decades of frontline healthcare leadership, we bring insight not just from theory but from the trenches. We partner with hospitals to optimize pharmacy operations, preserve revenue integrity, and ensure regulatory compliance. More than that, we help leaders anticipate challenges before they become crises.

The 340B program is more than a set of rules; it’s a tool to fulfill an organization’s mission of service.

By providing focused support, RDF ensures that hospitals can maintain the critical programs that touch the lives of countless patients.

In our first year, we’ve seen hospitals reclaim stability, improve operational efficiency, and continue serving their communities with confidence.

In 2026, as the landscape evolves further, hospitals will need partners who can navigate change with clarity, foresight, and compassion. RDF Consulting Group is here to ensure that mission-driven organizations continue to thrive — not just survive.